Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.
Sci Rep. 2017 Sep 11;7(1):11148. doi: 10.1038/s41598-017-11718-8.
Growth Factor Independence 1 (GFI1) is a transcriptional repressor that plays a critical role during both myeloid and lymphoid haematopoietic lineage commitment. Several studies have demonstrated the involvement of GFI1 in haematological malignancies and have suggested that low expression of GFI1 is a negative indicator of disease progression for both myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML). In this study, we have stratified AML patients into those defined as having a normal karyotype (CN-AML). Unlike the overall pattern in AML, those patients with CN-AML have a poorer survival rate when GFI1 expression is high. In this group, high GFI1 expression is paralleled by higher FLT3 expression, and, even when the FLT3 gene is not mutated, exhibit a FLT3-ITD signature of gene expression. Knock-down of GFI1 expression in the human AML Fujioka cell line led to a decrease in the level of FLT3 RNA and protein and to the down regulation of FLT3-ITD signature genes, thus linking two major prognostic indicators for AML.
生长因子独立性 1(GFI1)是一种转录抑制剂,在髓系和淋巴造血谱系的分化过程中起着关键作用。多项研究表明 GFI1 参与了血液系统恶性肿瘤的发生,并提示 GFI1 表达水平低是骨髓增生异常综合征(MDS)和急性髓系白血病(AML)疾病进展的负面指标。在这项研究中,我们将 AML 患者分为具有正常核型(CN-AML)的患者。与 AML 的整体模式不同,当 GFI1 表达较高时,CN-AML 患者的生存率较低。在这组患者中,高 GFI1 表达与更高的 FLT3 表达平行,即使 FLT3 基因未发生突变,也表现出 FLT3-ITD 基因表达特征。在人 AML Fujioka 细胞系中敲低 GFI1 表达会导致 FLT3 RNA 和蛋白质水平降低,并下调 FLT3-ITD 特征基因,从而将 AML 的两个主要预后指标联系起来。